Title |
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
|
Institution |
UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX
|
Principal Investigator |
KOPETZ, SCOTT
|
NCI Program Director |
Thurin
|
Cancer Activity |
Diagnostics Research
|
Division |
DCTD
|
Funded Amount |
$623,897
|
Project Dates |
02/13/2015 - 01/31/2020
|
Fiscal Year |
2017
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Digestive Diseases (100.0%)
Metastasis (50.0%)
|
Colon/Rectum (100.0%)
|
Research Type |
Technology Development and/or Marker Discovery
Systemic Therapies - Discovery and Development
|
Abstract |
No abstract available. |